Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system

Journal of Molecular and Cellular Cardiology

Volumn 75, Issue , 2014, Pages 25-39

  Kemp, Jacqueline R ^a,b   Unal, Hamiyet ^a   Desnoyer, Russell ^a   Yue, Hong ^a   Bhatnagar, Anushree ^a   Karnik, Sadashiva S ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Angiotensin II; AT1 receptor; Genome wide expression; MiRNA; Renin angiotensin system; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; ANTAGOMIR; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE 1; LOSARTAN; MICRORNA; MICRORNA 483 3P; UNCLASSIFIED DRUG; MIRN483 MICRORNA, HUMAN; MIRN483 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE RAS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA SEQUENCE; RNA STABILITY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STEADY STATE; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOME; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS; RATTUS; RODENTIA;

ANGIOTENSIN II; ANIMALS; BASE SEQUENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN SPECIFICITY; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84922748283     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.06.008     Document Type: Article

References (91)

1. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007, 292:C82-C97.
2. Lavoie J.L., Sigmund C.D. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003, 144:2179-2183.
3. Taubman M.B. Angiotensin II: a vasoactive hormone with ever-increasing biological roles. Circ Res 2003, 92:9-11.
4. Bader M., Peters J., Baltatu O., Muller D.N., Luft F.C., Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 2001, 79:76-102.
5. Lijnen P., Petrov V. renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 1999, 31:949-970.
6. Kim S., Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000, 52:11-34.
7. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000, 52:415-472.
8. Hunyady L., Catt K.J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 2006, 20:953-970.
9. Saito Y., Berk B.C. Angiotensin II-mediated signal transduction pathways. Curr Hypertens Rep 2002, 4:167-171.
10. Yin G., Yan C., Berk B.C. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 2003, 35:780-783.
11. Ohtsu H., Suzuki H., Nakashima H., Dhobale S., Frank G.D., Motley E.D., et al. Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells. Hypertension 2006, 48:534-540.
12. Touyz R.M., Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000, 52:639-672.
13. Bell L., Madri J.A. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 1990, 137:7-12.
14. Aplin M., Christensen G.L., Hansen J.L. Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor. Trends Cardiovasc Med 2008, 18:305-312.
15. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
16. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
17. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379.
18. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
19. Shukla G.C., Singh J., Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol 2011, 3:83-92.
20. Bhatt K., Mi Q.S., Dong Z. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. American Journal of Physiology Ren Physiol 2011, 300:F602-F610.
21. Elton T.S., Sansom S.E., Martin M.M. Cardiovascular disease, single nucleotide polymorphisms; and the renin angiotensin system: is there a microRNA Connection?. Int J Hypertens 2010, 2010.
22. Ikeda S., Pu W.T. Expression and function of microRNAs in heart disease. Curr Drug Targets 2010, 11:913-925.
23. Scalbert E., Bril A. Implication of microRNAs in the cardiovascular system. Curr Opin Pharmacol 2008, 8:181-188.
24. Boettger T., Beetz N., Kostin S., Schneider J., Kruger M., Hein L., et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009, 119:2634-2647.
25. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
26. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588.
27. Liu X., Cheng Y., Chen X., Yang J., Xu L., Zhang C. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem 2011, 286:42371-42380.
28. Villeneuve L.M., Kato M., Reddy M.A., Wang M., Lanting L., Natarajan R. Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 2010, 59:2904-2915.
29. Jin W., Reddy M.A., Chen Z., Putta S., Lanting L., Kato M., et al. Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem 2012, 287:15672-15683.
30. Naga Prasad S.V., Duan Z.H., Gupta M.K., Surampudi V.S., Volinia S., Calin G.A., et al. Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2009, 284:27487-27499.
31. Majors A.K., Sengupta S., Willard B., Kinter M.T., Pyeritz R.E., Jacobsen D.W. Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler Thromb Vasc Biol 2002, 22:1354-1359.
32. White S.M., Constantin P.E., Claycomb W.C. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 2004, 286:H823-H829.
33. Paradis P. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci 2000, 97:931-936.
34. Yue H., Li W., Desnoyer R., Karnik S.S. Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. Cardiovasc Res 2010, 85:90-99.
35. Chen J., Lozach J., Garcia E.W., Barnes B., Luo S., Mikoulitch I., et al. Highly sensitive and specific microRNA expression profiling using BeadArray technology. Nucleic Acids Res 2008, 36:e87.
36. Zhang X., Azhar G., Wei J.Y. The expression of microRNA and microRNA clusters in the aging heart. PLoS One 2012, 7:e34688.
37. Yu J., Wang F., Yang G.H., Wang F.L., Ma Y.N., Du Z.W., et al. Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun 2006, 349:59-68.
38. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
39. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
40. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
41. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
42. Lee S.D., Chu C.H., Huang E.J., Lu M.C., Liu J.Y., Liu C.J., et al. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am J Physiol Endocrinol Metab 2006, 291:E306-E314.
43. Richert L., Lamboley C., Viollon-Abadie C., Grass P., Hartmann N., Laurent S., et al. Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes. Toxicol Appl Pharmacol 2003, 191:130-146.
44. Dere E., Lee A.W., Burgoon L.D., Zacharewski T.R. Differences in TCDD-elicited gene expression profiles in human HepG2, mouse Hepa1c1c7 and rat H4IIE hepatoma cells. BMC Genomics 2011, 12:193.
45. Kim H.R., Park S.W., Cho H.J., Chae K.A., Sung J.M., Kim J.S., et al. Comparative gene expression profiles of intestinal transporters in mice, rats and humans. Pharmacol Res 2007, 56:224-236.
46. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
47. Chiang H.R., Schoenfeld L.W., Ruby J.G., Auyeung V.C., Spies N., Baek D., et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2010, 24:992-1009.
48. Romano G., Acunzo M., Garofalo M., Di Leva G., Cascione L., Zanca C., et al. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci U S A 2012, 109:16570-16575.
49. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010, 39:373-384.
50. Davis-Dusenbery B.N., Hata A. Smad-mediated miRNA processing: a critical role for a conserved RNA sequence. RNA Biol 2011, 8:71-76.
51. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS Biol 2005, 3:e85.
52. Ritter J.M. Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs). Br J Clin Pharmacol 2011, 71:313-315.
53. Rensen S.S., Doevendans P.A., van Eys G.J. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 2007, 15:100-108.
54. Daugherty A., Cassis L. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc Med 2004, 14:117-120.
55. Naga Prasad S.V., Karnik S.S. MicroRNAs-regulators of signaling networks in dilated cardiomyopathy. J Cardiovasc Transl Res 2010, 3:225-234.
56. Tarca A.L., Romero R., Draghici S. Analysis of microarray experiments of gene expression profiling. Am J Obstet Gynecol 2006, 195:373-388.
57. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866.
58. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 2004, 101:11755-11760.
59. Calin G.A., Trapasso F., Shimizu M., Dumitru C.D., Yendamuri S., Godwin A.K., et al. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005, 352:1667-1676.
60. Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005, 334:1351-1358.
61. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
62. Rayner K.J., Suarez Y., Davalos A., Parathath S., Fitzgerald M.L., Tamehiro N., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
63. Mishra P.K., Tyagi N., Kundu S., Tyagi S.C. MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell Biochem Biophys 2009, 55:153-162.
64. Veronese A., Lupini L., Consiglio J., Visone R., Ferracin M., Fornari F., et al. Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res 2010, 70:3140-3149.
65. Veronese A., Visone R., Consiglio J., Acunzo M., Lupini L., Kim T., et al. Mutated beta-catenin evades a microRNA-dependent regulatory loop. Proc Natl Acad Sci U S A 2011, 108:4840-4845.
66. Gingras B., Rodier G., Giasson E., Coulombe P., Chassagne C., Meloche S. Expression of angiotensin type II receptor downregulates Cdk4 synthesis and inhibits cell-cycle progression. Oncogene 2003, 22:2633-2642.
67. Bertero T., Gastaldi C., Bourget-Ponzio I., Mari B., Meneguzzi G., Barbry P., et al. CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest. Cell Death Differ 2013, 20:800-811.
68. Bertero T., Gastaldi C., Bourget-Ponzio I., Imbert V., Loubat A., Selva E., et al. miR-483-3p controls proliferation in wounded epithelial cells. FASEB J 2011, 25:3092-3105.
69. Bertero T., Bourget-Ponzio I., Puissant A., Loubat A., Mari B., Meneguzzi G., et al. Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties. Cell Cycle 2013, 12.
70. Ferland-McCollough D., Fernandez-Twinn D.S., Cannell I.G., David H., Warner M., Vaag A.A., et al. Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes. Cell Death Differ 2012, 19:1003-1012.
71. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009, 119:2772-2786.
72. Montgomery R.L., Hullinger T.G., Semus H.M., Dickinson B.A., Seto A.G., Lynch J.M., et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 2011, 124:1537-1547.
73. Tu Y., Gao X., Li G., Fu H., Cui D., Liu H., et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res 2013, 73:6046-6055.
74. Li C., Tu K., Zheng X., Zhang J., Tuo H., Gao J., et al. MicroRNA-218 expression and its role in hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 2013, 33:1127-1131.
75. Small E.M., Sutherland L.B., Rajagopalan K.N., Wang S., Olson E.N. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ Res 2010, 107:1336-1344.
76. Gao C., Zhang Z., Liu W., Xiao S., Gu W., Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010, 116:41-49.
77. Krichevsky A.M., Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009, 13:39-53.
78. Yu D.S., An F.M., Gong B.D., Xiang X.G., Lin L.Y., Wang H., et al. The regulatory role of microRNA-1187 in TNF-alpha-mediated hepatocyte apoptosis in acute liver failure. Int J Mol Med 2012, 29:663-668.
79. Zhang T., Luo Y., Wang T., Yang J.Y. MicroRNA-297b-5p/3p target Mllt3/Af9 to suppress lymphoma cell proliferation, migration and invasion in vitro and tumor growth in nude mice. Leuk Lymphoma 2012, 53:2033-2040.
80. Li P., Xu Q., Zhang D., Li X., Han L., Lei J., et al. Upregulated miR-106a plays an oncogenic role in pancreatic cancer. FEBS Lett 2014, 588:705-712.
81. Landais S., Landry S., Legault P., Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007, 67:5699-5707.
82. Jiang Y., Wu Y., Greenlee A.R., Wu J., Han Z., Li X., et al. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide. Toxicol Sci 2011, 119:50-60.
83. Wang Y.X., Zhang X.Y., Zhang B.F., Yang C.Q., Chen X.M., Gao H.J. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 2010, 11:50-54.
84. Funamizu N., Lacy C.R., Parpart S.T., Takai A., Hiyoshi Y., Yanaga K. MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells. Int J Oncol 2014, 44:725-734.
85. Jalava S.E., Urbanucci A., Latonen L., Waltering K.K., Sahu B., Janne O.A., et al. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Oncogene 2012, 31:4460-4471.
86. Wu W., Yang J., Feng X., Wang H., Ye S., Yang P., et al. MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer 2013, 12:30.
87. Zhang J., Kuai X., Song M., Chen X., Yu Z., Zhang H., et al. microRNA-32 inhibits the proliferation and invasion of the SGC-7901 gastric cancer cell line. Oncol Lett 2014, 7:270-274.
88. Lazar L., Nagy B., Molvarec A., Szarka A., Rigo J. Role of hsa-miR-325 in the etiopathology of preeclampsia. Mol Med Rep 2012, 6:597-600.
89. Zheng G.X., Ravi A., Gould G.M., Burge C.B., Sharp P.A. Genome-wide impact of a recently expanded microRNA cluster in mouse. Proc Natl Acad Sci U S A 2011, 108:15804-15809.
90. Ahn J., Lee H., Chung C.H., Ha T. High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis. Biochem Biophys Res Commun 2011, 414:664-669.
91. Chen Y., Gelfond J., McManus L.M., Shireman P.K. Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682. Physiol Genomics 2011, 43:621-630.